Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
149.12
+2.70 (1.84%)
At close: Jun 9, 2026, 4:00 PM EDT
148.10
-1.02 (-0.68%)
After-hours: Jun 9, 2026, 7:00 PM EDT
Novartis AG Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 13,514 | 13,967 | 11,939 | 8,572 | 6,049 | 22,905 |
Depreciation & Amortization | 5,288 | - | 6,114 | 8,383 | 6,965 | 5,559 |
Stock-Based Compensation | 1,137 | - | 1,044 | 865 | 791 | 700 |
Other Adjustments | -168 | -4,475 | -772 | -3,231 | 30 | -15,726 |
Change in Receivables | -585 | - | -931 | -1,504 | -397 | -352 |
Changes in Inventories | -116 | - | -225 | -546 | -560 | -102 |
Changes in Accounts Payable | -154 | - | -105 | 479 | -181 | -111 |
Changes in Accrued Expenses | 431 | - | 1,057 | 1,327 | 426 | 671 |
Changes in Other Operating Activities | -768 | -1,577 | -1,208 | -494 | -880 | -252 |
Operating Cash Flow | 19,175 | 19,144 | 17,619 | 14,458 | 14,236 | 15,071 |
Operating Cash Flow Growth | 0.93% | 8.65% | 21.86% | 1.56% | -5.54% | 10.41% |
Capital Expenditures | -1,640 | -1,548 | -1,366 | -1,060 | -916 | -1,066 |
Sale of Property, Plant & Equipment | 8 | 13 | 86 | 237 | 158 | 211 |
Purchases of Intangible Assets | -1,573 | -2,352 | -2,448 | -1,693 | -1,323 | -1,490 |
Proceeds from Sale of Intangible Assets | 164 | 164 | 80 | 1,955 | 170 | 686 |
Purchases of Investments | -303 | -303 | -3,648 | -747 | -34,811 | -16,591 |
Proceeds from Sale of Investments | 1,467 | 2,177 | 3,701 | 11,596 | 39,490 | 2,742 |
Payments for Business Acquisitions | -14,968 | -2,916 | -4,018 | -3,561 | -840 | -205 |
Proceeds from Business Divestments | -75 | -88 | 107 | 3 | - | - |
Other Investing Activities | -23 | -24 | -7 | -1,134 | -460 | 19,977 |
Investing Cash Flow | -16,943 | -4,877 | -7,513 | 5,596 | 1,468 | 4,208 |
Short-Term Debt Issued | 196 | 5 | 958 | 546 | 252 | -3,547 |
Net Short-Term Debt Issued (Repaid) | 196 | 5 | 958 | 546 | 252 | -3,547 |
Long-Term Debt Issued | 17,016 | 6,098 | 6,143 | - | - | - |
Long-Term Debt Repaid | -2,401 | -3,392 | -2,160 | -2,223 | -2,575 | -2,162 |
Net Long-Term Debt Issued (Repaid) | 14,615 | 2,706 | 3,983 | -2,223 | -2,575 | -2,162 |
Issuance of Common Stock | 26 | 27 | 30 | 153 | 100 | 53 |
Repurchase of Common Stock | -8,371 | -9,212 | -8,331 | -8,719 | -10,652 | -3,057 |
Net Common Stock Issued (Repurchased) | -8,345 | -9,185 | -8,301 | -8,566 | -10,552 | -3,004 |
Common Dividends Paid | -8,682 | -7,818 | -7,624 | -7,255 | -7,506 | -7,368 |
Other Financing Activities | -524 | -575 | -758 | 3,220 | -181 | -180 |
Financing Cash Flow | -2,740 | -14,867 | -11,742 | -14,278 | -20,562 | -16,264 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 319 | 576 | -298 | 100 | -32 | -266 |
Net Cash Flow | -189 | -24 | -1,934 | 5,876 | -4,890 | 2,749 |
Free Cash Flow | 17,535 | 17,596 | 16,253 | 13,398 | 13,320 | 14,005 |
Free Cash Flow Growth | -0.35% | 8.26% | 21.31% | 0.59% | -4.89% | 13.17% |
FCF Margin | 30.99% | 31.05% | 31.42% | 28.71% | 30.65% | 31.85% |
Free Cash Flow Per Share | 9.06 | 9.00 | 7.99 | 6.40 | 6.06 | 6.20 |
Levered Free Cash Flow | 31,386 | 13,570 | 21,149 | 21,262 | 9,486 | 23,011 |
Unlevered Free Cash Flow | 17,781 | 11,946 | 16,997 | 17,268 | 11,551 | 14,089 |